Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released May 8, 2023, after the close
10-Q filed May 8, 2023, 38 days after period end · 0000950170-23-018927
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $118.46M | $115.47M | $106.55M | $90.07M |
| Net Income | -$43.02M | -$113.06M | -$66.45M | -$88.02M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.27 |
| -$0.70 |
| -$0.42 |
| -$0.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
